- Home
- FTRE vs GBLI Comparison
FTRE vs GBLI Comparison
Compare FTRE & GBLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- GBLI
- Stock Information
- Founded
- FTRE 1996
- GBLI 2016
- Country
- FTRE United States
- GBLI United States
- Employees
- FTRE N/A
- GBLI N/A
- Industry
- FTRE Medical Specialities
- GBLI Property-Casualty Insurers
- Sector
- FTRE Health Care
- GBLI Finance
- Exchange
- FTRE Nasdaq
- GBLI Nasdaq
- Market Cap
- FTRE 469.0M
- GBLI 443.7M
- IPO Year
- FTRE N/A
- GBLI 2003
- Fundamental
- Price
- FTRE $5.22
- GBLI $31.00
- Analyst Decision
- FTRE Hold
- GBLI
- Analyst Count
- FTRE 11
- GBLI 0
- Target Price
- FTRE $17.10
- GBLI N/A
- AVG Volume (30 Days)
- FTRE 2.9M
- GBLI 811.0
- Earning Date
- FTRE 08-11-2025
- GBLI 08-06-2025
- Dividend Yield
- FTRE N/A
- GBLI 4.47%
- EPS Growth
- FTRE N/A
- GBLI N/A
- EPS
- FTRE N/A
- GBLI 1.99
- Revenue
- FTRE $2,685,600,000.00
- GBLI $437,447,000.00
- Revenue This Year
- FTRE N/A
- GBLI $7.67
- Revenue Next Year
- FTRE $1.36
- GBLI $7.93
- P/E Ratio
- FTRE N/A
- GBLI $15.74
- Revenue Growth
- FTRE N/A
- GBLI N/A
- 52 Week Low
- FTRE $3.97
- GBLI $26.94
- 52 Week High
- FTRE $28.41
- GBLI $37.00
- Technical
- Relative Strength Index (RSI)
- FTRE 49.64
- GBLI 47.92
- Support Level
- FTRE $4.81
- GBLI $31.32
- Resistance Level
- FTRE $5.63
- GBLI $34.00
- Average True Range (ATR)
- FTRE 0.35
- GBLI 0.48
- MACD
- FTRE -0.01
- GBLI -0.17
- Stochastic Oscillator
- FTRE 30.37
- GBLI 26.92
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance world-wide. The company's two segments are: Penn-America and Non-Core Operations. The Penn-America segment offers specialty property and casualty products designed for its Wholesale Commercial, Specialty Products, InsurTech, and Assumed Reinsurance product offerings. These product lines are offered in the excess and surplus lines marketplace; and Non-Core Operations segment contains lines of business that have been de-emphasized or are no longer being written. The majority of its revenue is from the the Penn-America segment . Geographically, the majority is from California.